Archynetys Live news trend intelligence
↓ Cooling Health

A Beaver County man is part of a clinical trial for a brain implant that collapses the time usually needed between surgery and radiation - Pittsburgh Post-Gazette

A new brain implant technology is redefining postoperative radiation treatment for brain metastases by reducing the time between surgery and radiation.

5sources
5articles
3velocity
-80%since first seen
20m agofirst detected

Velocity

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

The brief

A brain implant known as GammaTile is being used to treat brain tumors and metastases. The technology allows for radiation therapy to be administered more quickly following surgery.

A man from Beaver County is currently participating in a clinical trial for the device. Coverage from Oncodaily, The ASCO Post, and the Pittsburgh Post-Gazette emphasizes the Phase III ROADS trial and the device's ability to collapse the traditional timeline between surgery and radiation.

Additionally, Ballad Health has introduced the therapy, and OHSU is the first provider in Oregon to implant the device. Future developments center on the results of the Phase III ROADS trial and the continued rollout of the therapy across healthcare systems.

Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 18m ago.

Quick answers

What is GammaTile?

It is a tile-based brain implant used to deliver radiation therapy for brain metastases and tumors.

Which clinical trial is associated with this technology?

The technology is being evaluated in the Phase III ROADS trial.

Where is the device being implemented?

Coverage identifies its use at OHSU in Oregon, Ballad Health, and in a clinical trial involving a Beaver County man.

Coverage (5)

Topics

Related trends